PlainRecalls
FDA Drug Moderate Class II Terminated

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC# 72578-036-01

Reported: February 2, 2022 Initiated: December 27, 2021 #D-0392-2022

Product Description

Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC# 72578-036-01

Reason for Recall

CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Details

Recalling Firm
VIONA PHARMACEUTICALS INC
Units Affected
23,8416/100 count bottles
Distribution
Product was distributed to 17 wholesalers who further distributed the product to 85 locations.
Location
Cranford, NJ

Frequently Asked Questions

What product was recalled?
Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 count HDPE bottles NDC# 72578-036-01. Recalled by VIONA PHARMACEUTICALS INC. Units affected: 23,8416/100 count bottles.
Why was this product recalled?
CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 2, 2022. Severity: Moderate. Recall number: D-0392-2022.